Looking at the expression levels of these proteins in patients suffering from diabetic nephropathy (DN), we found a down-regulation of the expression (log2 fold change: SIRPA: -0.902; IQGAP2: -0.578) (Fig. 3g). Here, SIRPA is linked to diabetic kidney disease.